Target
Tyrosine-protein kinase JAK3 [795-1124]
Ligand
BDBM458891
Substrate
n/a
Meas. Tech.
In Vitro JAK kinase Assays
IC50
1.000±n/a nM
Citation
 Esteve Trias, CTaltavull Moll, JGonzalez Rodriguez, JVidal Juan, B 2-(pyrazolopyridin-3-yl)pyrimidine derivatives as JAK inhibitors US Patent  US10759793 Publication Date 9/1/2020 
Target
Name:
Tyrosine-protein kinase JAK3 [795-1124]
Synonyms:
JAK3 | JAK3_HUMAN | Tyrosine-protein kinase JAK3 (795-1124)
Type:
Enzyme Catalytic Domain
Mol. Mass.:
37299.74
Organism:
Homo sapiens (Human)
Description:
aa 795-1124
Residue:
330
Sequence:
ALAPRDGLWNGAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS
  
Inhibitor
Name:
BDBM458891
Synonyms:
US10759793, Example 43
Type:
Small organic molecule
Emp. Form.:
C18H19FN6O3
Mol. Mass.:
386.3803
SMILES:
OCC(=O)N1CCC[C@H](C1)Nc1nc(nc(O)c1F)-c1cnn2ccccc12
Structure:
Search PDB for entries with ligand similarity: